Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography

J Chromatogr B Biomed Appl. 1996 Dec 13;687(2):437-42. doi: 10.1016/s0378-4347(96)00254-x.

Abstract

A selective high-performance liquid chromatographic method to assess either bezafibrate, ciprofibrate or fenofibric acid plasma levels is described. Drugs are extracted with diethyl ether, after acidification with HCL. An isocratic acetonitrile 0.02 M H3PO4 (55:45) mobile phase, a C18 microns) column and UV detection are used. The LOQ found was 0.25 microgram/ml for the three fibrates. Intra- and inter-assay accuracy ranges were 90-107% and 82-111%: 96-115% and 94-107%: 94-114% and 94-126% for bezafibrate, ciprofibrate and fenofibric acid, respectively. Intra- and inter-assay precision (C.V.% ranges) were 1.72-3.06% and 2.66-7.67%: 1.88-4.64% and 0.62-2.99%: 1.26-4.69% and 3.56-7.17% for the three fibrates studied. Its sensitivity, accuracy and precision make it a useful tool for monitoring plasma levels of these drugs in a clinical setting and for research purposes.

MeSH terms

  • Bezafibrate / blood*
  • Calibration
  • Chromatography, High Pressure Liquid / methods*
  • Clofibric Acid / analogs & derivatives*
  • Clofibric Acid / blood
  • Fenofibrate / analogs & derivatives*
  • Fenofibrate / blood
  • Fibric Acids
  • Humans
  • Hypolipidemic Agents / blood*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Fibric Acids
  • Hypolipidemic Agents
  • Clofibric Acid
  • fenofibric acid
  • ciprofibrate
  • Fenofibrate
  • Bezafibrate